“If this blog helped you out, don’t keep it to yourself—share the link on your socials!” 👍 “Like what you read? Spread the love and share this blog on your social media.” 👍 “Found this useful? Hit share and let your friends know too!” 👍 “If you enjoyed this post, please share the URL with your friends online.” 👍 “Sharing is caring—drop this link on your social media if it helped you.”

Sunday, August 31, 2025

Blue Earth Diagnostics


Blue Earth Diagnostics products

Axumin®

  • Generic: fluciclovine F-18

  • Indication: PET imaging for suspected prostate cancer recurrence in men with elevated PSA

  • Usage / Notes: Administered via PET scan to help detect and localize recurrent prostate cancer

POSLUMA®

  • Generic: flotufolastat F-18 (formerly referred to as rhPSMA-7.3)

  • Indication: PET imaging of PSMA-positive lesions in men with prostate cancer—either suspected metastasis (in candidates for initial definitive therapy) or suspected recurrence based on elevated PSA

  • Usage / Notes: Delivered as a diagnostic PET radiopharmaceutical; part of a new radiohybrid (rh) class offering high-affinity PSMA targeting and advanced image quality

Investigational Pipeline Products

  • fluciclovine F-18 (for brain metastases) – under clinical development for PET imaging of brain metastases

  • FAP-targeted radiopharmaceuticals – under investigation via PET imaging across multiple solid tumor types




on

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)